nodes	percent_of_prediction	percent_of_DWPC	metapath
Bacitracin—IDE—nephron tubule—focal segmental glomerulosclerosis	0.0773	0.252	CbGeAlD
Bacitracin—IDE—cortex of kidney—focal segmental glomerulosclerosis	0.0661	0.216	CbGeAlD
Bacitracin—A2M—nephron tubule—focal segmental glomerulosclerosis	0.0595	0.194	CbGeAlD
Bacitracin—A2M—IL6-mediated signaling events—PIAS1—focal segmental glomerulosclerosis	0.0552	0.0796	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.0527	0.076	CbGpPWpGaD
Bacitracin—A2M—kidney—focal segmental glomerulosclerosis	0.0523	0.171	CbGeAlD
Bacitracin—A2M—cortex of kidney—focal segmental glomerulosclerosis	0.0509	0.166	CbGeAlD
Bacitracin—A2M—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.0465	0.0671	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.0429	0.0619	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.0409	0.059	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.0397	0.0572	CbGpPWpGaD
Bacitracin—A2M—HDL-mediated lipid transport—ALB—focal segmental glomerulosclerosis	0.0325	0.0468	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.0309	0.0446	CbGpPWpGaD
Bacitracin—A2M—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.0284	0.0409	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.019	0.0275	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.0189	0.0272	CbGpPWpGaD
Bacitracin—A2M—Lipoprotein metabolism—ALB—focal segmental glomerulosclerosis	0.0186	0.0269	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.0139	0.02	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.0128	0.0184	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—ALB—focal segmental glomerulosclerosis	0.0124	0.0179	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—SPP1—focal segmental glomerulosclerosis	0.0113	0.0162	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.0108	0.0155	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—FN1—focal segmental glomerulosclerosis	0.0102	0.0148	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.00982	0.0142	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	0.00976	0.0141	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.00914	0.0132	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	0.00852	0.0123	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—ALB—focal segmental glomerulosclerosis	0.00851	0.0123	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	0.00812	0.0117	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—ALB—focal segmental glomerulosclerosis	0.0081	0.0117	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP2—focal segmental glomerulosclerosis	0.00798	0.0115	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.00764	0.011	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.00657	0.00947	CbGpPWpGaD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP9—focal segmental glomerulosclerosis	0.00599	0.00864	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	0.00538	0.00775	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	0.00513	0.00739	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.00472	0.00681	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00471	0.00679	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.00454	0.00655	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00442	0.00637	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.00394	0.00568	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00394	0.00568	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00389	0.00561	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.00378	0.00545	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.00377	0.00544	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.00334	0.00482	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.00328	0.00473	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0028	0.00403	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.0027	0.00389	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00257	0.0037	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	0.00251	0.00362	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00239	0.00344	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00234	0.00338	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00231	0.00334	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00231	0.00333	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00217	0.00313	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	0.00207	0.00298	CbGpPWpGaD
Bacitracin—A2M—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00197	0.00284	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00195	0.00281	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00194	0.0028	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00177	0.00255	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00173	0.0025	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0016	0.0023	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.0016	0.0023	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00159	0.00229	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00134	0.00192	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00123	0.00177	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00122	0.00176	CbGpPWpGaD
Bacitracin—A2M—Metabolism—LPL—focal segmental glomerulosclerosis	0.0012	0.00173	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00104	0.00149	CbGpPWpGaD
Bacitracin—A2M—Metabolism—AGT—focal segmental glomerulosclerosis	0.00103	0.00148	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.001	0.00145	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000951	0.00137	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000859	0.00124	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000794	0.00114	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ALB—focal segmental glomerulosclerosis	0.000789	0.00114	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000661	0.000952	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000506	0.000729	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000417	0.000601	CbGpPWpGaD
